Medical Devices Startups
6,526 companies tagged Medical Devices, with their investors and founders.
Encision develops shielded laparoscopic surgical instruments using Active Electrode Monitoring (AEM) technology to prevent stray energy burns from insulation failure and capacitive coupling during minimally invasive surgery. Its products, including reposable scissors and shielded instruments, are marketed to hospitals and surgeons for general surgery and gynecologic procedures in the USA.
0 investors
Encore Medical develops cardiovascular medical devices, with clinical work focused on patent foramen ovale (PFO) and related conditions such as migraine. It operates in the cardiovascular medical device sector.
0 investors
Endeavor Orthopaedics develops a patella fracture plating system that integrates treatment of bony fractures and soft-tissue injuries in orthopedic surgery. The company's Summit system addresses the full extensor mechanism to reduce surgical failures and repeat operations.
0 investors
Endolumik develops a fluorescence-guided esophagogastric calibration system (bougie) that uses near-infrared light to illuminate the stomach from within, helping surgeons see the calibration tube through tissue during bariatric and gastrointestinal procedures. The device targets surgical teams performing robotic and laparoscopic operations such as gastric sleeve and gastric pouch surgeries.
0 investors
Endoluxe develops a wireless endoscopy platform for medical and surgical use, aimed at physicians and healthcare providers. The company operates in the medical device (endoscopy) sector.
0 investors
Endonovo Therapeutics is a commercial-stage developer of non-invasive, wearable medical devices that deliver its Electroceutical Therapy, which uses bioelectricity to treat inflammatory conditions, cardiovascular diseases, and central nervous system disorders. Its therapy is FDA-cleared and CE-marked for pain, post-surgical edema, and wound healing, with a clinical-stage pipeline targeting ischemic heart disease, concussions, traumatic brain injury, and multiple sclerosis.
0 investors
Endotheia develops next-generation flexible endoscopy technology and products for medical procedures.
0 investors
Engraft Technologies develops surgical instruments for hair transplant surgery, including the Duplex Implanter, aimed at improving the safety, consistency, and efficiency of the procedure for practitioners. The company operates in the medical device and hair restoration field.
0 investors
Eniware develops a power-free, portable sterilization device that adapts Noxilizer's nitrogen dioxide (NO2) sterilant technology to provide sterilization capacity without electricity or water. It targets health professionals delivering safe essential surgery in resource-limited settings such as rural hospitals, refugee camps, military field units, and disaster zones.
0 investors
Ensysce is a pharmaceutical development company focused on developing safer medicines, with particular expertise in pain management and opioid-related drug development. The team has extensive experience bringing targeted small molecule drugs and oncology compounds from discovery through clinical development to market approval.
0 investors
EnteroTrack develops the Esophageal String Test (EnteroTracker), a non-endoscopic, in-office test that measures eosinophil-associated proteins to generate an EoEScore for monitoring Eosinophilic Esophagitis (EoE). The device serves gastroenterologists and allergists as a surveillance tool that correlates with biopsy eosinophil counts and endoscopic severity.
0 investors
Enterra Medical develops implantable gastric electrical stimulation devices for treating chronic gastroparesis symptoms resistant to medication. The company serves patients with nausea and vomiting associated with gastroparesis caused by diabetes or unknown origin.
0 investors
Epalex is a clinical-stage pharmaceutical company developing therapies for migraine and epilepsy, focused on patients who are inadequately treated by or resistant to existing drugs. Its pipeline includes EP102 for hard-to-treat migraine and EP103, a non-benzodiazepine antiseizure agent for drug-refractory epilepsy, using a proprietary delivery technology.
0 investors
EPIEN Medical develops a proprietary chemical desiccation-based debridement platform for treating impaired skin tissue and managing wounds, burns, and oral disease. The company serves healthcare professionals and veterinary practitioners globally.
0 investors
Provides sleep apnea diagnostics and treatment through telemedicine consults, home and in-center sleep studies, and therapy and coaching, serving patients and referring physicians. Operates across New England with a virtual-first approach and in-clinic locations.
0 investors
Equity Dental provides dental care services with a focus on accessibility across diverse communities regardless of socioeconomic status or demographics. The organization operates as a dental practice aimed at eradicating oral health infections through preventative and clinical care.
0 investors
Evogen develops proteomics and genomics diagnostic technologies for neurology precision medicine, including a biomarker-based blood test (EvoScore) for epilepsy and seizure diagnosis. The company also offers HyBeacons PCR reagent technology for pathogen detection and the SpinCon air sampler for collecting airborne biothreats, serving healthcare providers and biodefense applications.
0 investors
Evolus is an aesthetics company that markets Jeuveau, an injectable neurotoxin treatment offered through providers, along with a membership program (Club Evolus) for consumers. It operates in the medical aesthetics and pharmaceutical products space.
0 investors
Exactics Biotech develops rapid diagnostic tests for at-home use, starting with Lyme disease detection in ticks and a broader at-home lab platform. The company focuses on diagnostic products that prioritize sensitivity, affordability, and ease of use.
0 investors
ExAI develops technology for early cancer detection, diagnosis, and management. The company serves healthcare providers and patients in the oncology space.
0 investors
Excelent Medical offers a platform for independent ENT (otolaryngology) practices combining in-office sinus medical devices (such as balloon and microdebrider products) with software tools for patient prospecting, AI-driven scheduling, and revenue cycle management. Built by practicing otolaryngologists, it targets independent ENT practices, with partner practices in North Carolina, South Carolina, Georgia, and Florida.
0 investors
The company develops expansion microscopy technology that enables nanoscale imaging of large brain tissue sections by permeating them with absorbent material and expanding with water, preserving molecular information.
0 investors
Eyedaptic develops software-driven smart glasses that use augmented reality and AI to enhance the remaining vision of people with central vision loss from retinal conditions such as age-related macular degeneration, diabetic retinopathy, and Stargardt's disease. Its products include the EYE7 glasses and IVY, a generative AI visual assistant.
0 investors
EZaccessMD combines 24/7 nationwide telehealth with in-home diagnostics, sending medical technicians to patients' homes with equipment for X-rays, EKGs, and rapid tests to reduce unnecessary urgent care and ER visits. It serves employers and self-funded health plans as an employee benefit, with in-home diagnostic coverage in 22 US states.
0 investors